BG108217A - Метод за инхибиране на адхезия - Google Patents

Метод за инхибиране на адхезия Download PDF

Info

Publication number
BG108217A
BG108217A BG108217A BG10821703A BG108217A BG 108217 A BG108217 A BG 108217A BG 108217 A BG108217 A BG 108217A BG 10821703 A BG10821703 A BG 10821703A BG 108217 A BG108217 A BG 108217A
Authority
BG
Bulgaria
Prior art keywords
alkyl
het
cor
cycloalkyl
halogen
Prior art date
Application number
BG108217A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert Willette
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG108217A publication Critical patent/BG108217A/bg

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG108217A 2001-04-10 2003-10-01 Метод за инхибиране на адхезия BG108217A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28269301P 2001-04-10 2001-04-10

Publications (1)

Publication Number Publication Date
BG108217A true BG108217A (bg) 2004-12-30

Family

ID=23082703

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108217A BG108217A (bg) 2001-04-10 2003-10-01 Метод за инхибиране на адхезия

Country Status (26)

Country Link
EP (1) EP1385504B1 (fr)
JP (1) JP4394882B2 (fr)
KR (1) KR20030087069A (fr)
CN (1) CN1248692C (fr)
AP (1) AP2003002894A0 (fr)
AT (1) ATE417612T1 (fr)
AU (1) AU2002305164B2 (fr)
BG (1) BG108217A (fr)
BR (1) BR0208789A (fr)
CA (1) CA2443734A1 (fr)
CZ (1) CZ20032767A3 (fr)
DE (1) DE60230404D1 (fr)
EA (1) EA006202B1 (fr)
EC (1) ECSP034799A (fr)
ES (1) ES2319877T3 (fr)
HU (1) HUP0303725A3 (fr)
IL (1) IL158272A0 (fr)
MA (1) MA26159A1 (fr)
MX (1) MXPA03009344A (fr)
NO (1) NO20034513L (fr)
NZ (1) NZ528577A (fr)
OA (1) OA12505A (fr)
PL (1) PL364526A1 (fr)
UA (1) UA75395C2 (fr)
WO (1) WO2002083125A1 (fr)
ZA (1) ZA200307621B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200635902A (en) * 2004-12-21 2006-10-16 Smithkline Beecham Corp Methods and formulations
RU2744540C1 (ru) * 2020-02-18 2021-03-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ профилактики спаечного процесса при операциях на брюшной полости в условиях паренхиматозного кровотечения в эксперименте

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60311C2 (uk) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція

Also Published As

Publication number Publication date
WO2002083125A1 (fr) 2002-10-24
OA12505A (en) 2006-05-29
CA2443734A1 (fr) 2002-10-24
DE60230404D1 (fr) 2009-01-29
NO20034513L (no) 2003-12-04
CZ20032767A3 (cs) 2004-12-15
BR0208789A (pt) 2004-03-09
ATE417612T1 (de) 2009-01-15
IL158272A0 (en) 2004-05-12
EA006202B1 (ru) 2005-10-27
EP1385504A4 (fr) 2007-03-14
CN1248692C (zh) 2006-04-05
ZA200307621B (en) 2004-04-21
EP1385504A1 (fr) 2004-02-04
ECSP034799A (es) 2004-01-28
ES2319877T3 (es) 2009-05-14
MXPA03009344A (es) 2004-02-12
EP1385504B1 (fr) 2008-12-17
HUP0303725A2 (hu) 2004-03-01
MA26159A1 (fr) 2004-07-01
UA75395C2 (en) 2006-04-17
JP4394882B2 (ja) 2010-01-06
PL364526A1 (en) 2004-12-13
NZ528577A (en) 2005-01-28
EA200301109A1 (ru) 2004-02-26
KR20030087069A (ko) 2003-11-12
AU2002305164B2 (en) 2005-07-28
CN1509170A (zh) 2004-06-30
NO20034513D0 (no) 2003-10-08
HUP0303725A3 (en) 2009-08-28
AP2003002894A0 (en) 2003-12-31
JP2004525959A (ja) 2004-08-26

Similar Documents

Publication Publication Date Title
US20220152058A1 (en) Methods and compositions for treating various disorders
JPWO2003043655A1 (ja) 頻尿の治療剤
JP2000507544A (ja) 痛みの治療方法
BR112020003973A2 (pt) combinação de agentes ativos para o tratamento de doenças pulmonares intersticiais fibrosantes progressivas (pf-ild)
JP2003012557A (ja) 不安及びうつ病のための多剤併用治療
BRPI0610498A2 (pt) uso de roflumilast,composição farmacêutica, produto de combinação e kit para o tratamento de hipertensão pulmonar
ZA200105275B (en) New use of melagatran.
Eggleston et al. Use of a hyaluronate membrane for jejunal anastomosis in horses
ES2359721T3 (es) Composición farmacéutica para el tratamiento de fracturas óseas.
BG108217A (bg) Метод за инхибиране на адхезия
JP5244089B2 (ja) 鎮痛剤およびビタミンを含む医薬組成物
AU2002305164A1 (en) Method of inhibiting adhesion formation
Kan et al. Differential action of anti-emetic drugs on defecation and emesis induced by prostaglandin E2 in the ferret
US20040142918A1 (en) Method of inhibiting adhesion formation
JPH089538B2 (ja) 卒中治療用薬剤
KR20020074513A (ko) 변형성 관절증 치료제
WO2022106851A1 (fr) Mebendazole pour une utilisation dans le traitement de la polykystose rénale autosomique dominante ou de la polykystose rénale autosomique récessive
JPS59157021A (ja) 動脈硬化症予防治療剤
JP2012136478A (ja) 骨壊死予防及び/又は治療剤
JP2002541099A (ja) 免疫調節組成物およびその使用方法
MXPA01007833A (es) Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria.
JP2005041801A (ja) 細胞移植療法後の予後改善剤
LT5474B (lt) 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimui
CZ2000292A3 (cs) Farmaceutický prostředek aktivní při snižování produkce proteinu MCP-1
JPS6259209A (ja) 2−アミノメチルフエノ−ル誘導体を有効成分として含有する抗動脈硬化剤